The findings revealed aberrant levels in eight marker genes within BC specimens, namely PTGS2, BIRC3, PRKCQ, NRAS, CDH3, LRP1, FASN, and SIRT6 (depicted in Fig. 5A). This evidence concerns the gene NRAS and breast cancer.